Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Synlogic Inc (SYBX)

Synlogic Inc (SYBX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 20,732
  • Shares Outstanding, K 11,647
  • Annual Sales, $ 3,370 K
  • Annual Income, $ -57,280 K
  • 60-Month Beta 1.09
  • Price/Sales 6.15
  • Price/Cash Flow N/A
  • Price/Book 0.39
Trade SYBX with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate -1.50
  • Number of Estimates 2
  • High Estimate -0.80
  • Low Estimate -2.19
  • Prior Year -3.45
  • Growth Rate Est. (year over year) +56.52%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.7000 +5.29%
on 03/28/24
2.0400 -12.25%
on 03/19/24
-0.0800 (-4.28%)
since 02/28/24
3-Month
1.5500 +15.48%
on 02/13/24
5.1181 -65.03%
on 01/03/24
-1.6600 (-48.12%)
since 12/28/23
52-Week
1.5500 +15.48%
on 02/13/24
10.6410 -83.18%
on 04/17/23
-7.3900 (-80.50%)
since 03/28/23

Most Recent Stories

More News
Synlogic, Inc. (SYBX) Reports Q1 Loss, Lags Revenue Estimates

Synlogic, Inc. (SYBX) delivered earnings and revenue surprises of 8% and 3.33%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

SYBX : 1.7900 (+0.56%)
STRO : 5.65 (+14.60%)
SQZ Biotechnologies Company (SQZ) Reports Q1 Loss, Misses Revenue Estimates

SQZ Biotechnologies Company (SQZ) delivered earnings and revenue surprises of -11.11% and 100%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?...

SQZ : 0.4350 (+61.11%)
SYBX : 1.7900 (+0.56%)
Analysts Estimate Synlogic, Inc. (SYBX) to Report a Decline in Earnings: What to Look Out for

Synlogic, Inc. (SYBX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

SYBX : 1.7900 (+0.56%)
STOK : 13.50 (-4.73%)
Synlogic, Inc. (SYBX) Reports Q4 Loss, Misses Revenue Estimates

Synlogic, Inc. (SYBX) delivered earnings and revenue surprises of 7.69% and 73.50%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

SYBX : 1.7900 (+0.56%)
ALIM : 3.90 (unch)
Humacyte, Inc. (HUMA) Reports Q4 Loss, Misses Revenue Estimates

Humacyte, Inc. (HUMA) delivered earnings and revenue surprises of 12.50% and 100%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

HUMA : 3.11 (+0.32%)
SYBX : 1.7900 (+0.56%)
TELA Bio, Inc. (TELA) Reports Q4 Loss, Lags Revenue Estimates

TELA Bio, Inc. (TELA) delivered earnings and revenue surprises of 10.34% and 12.62%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

TELA : 5.67 (+1.07%)
SYBX : 1.7900 (+0.56%)
Synlogic, Inc. (SYBX) Upgraded to Buy: Here's Why

Synlogic, Inc. (SYBX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

SYBX : 1.7900 (+0.56%)
Synlogic, Inc. (SYBX) Reports Q3 Loss, Tops Revenue Estimates

Synlogic, Inc. (SYBX) delivered earnings and revenue surprises of -8.70% and 93.71%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

SYBX : 1.7900 (+0.56%)
ALIM : 3.90 (unch)
Synlogic Announces Synthetic Biotic for Gout Developed in Partnership with Ginkgo Bioworks

/PRNewswire/ -- Synlogic, Inc. (Nasdaq: SYBX), a clinical-stage biotechnology company developing medicines for metabolic and immunological diseases through its...

SYBX : 1.7900 (+0.56%)
DNA : 1.1600 (+5.45%)
Synlogic Reports Second Quarter 2022 Financial Results and Provides Business Update

– Three clinical data readouts across three programs expected in H2 2022 – – PKU Phase 3 readiness activities underway for planned start in H1 2023 – – ...

SYBX : 1.7900 (+0.56%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Synlogic, Inc. engaged in the development of a novel class of living Synthetic Biotic(TM) medicines based on its proprietary drug discovery and development platform. The company's pipeline includes Synthetic Biotic medicines for the treatment of rare genetic diseases such as Urea Cycle Disorder and Phenylketonuria....

See More

Key Turning Points

3rd Resistance Point 2.0017
2nd Resistance Point 1.9233
1st Resistance Point 1.8567
Last Price 1.7900
1st Support Level 1.7117
2nd Support Level 1.6333
3rd Support Level 1.5667

See More

52-Week High 10.6410
Fibonacci 61.8% 7.1682
Fibonacci 50% 6.0955
Fibonacci 38.2% 5.0228
Last Price 1.7900
52-Week Low 1.5500

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar